NCT04330521Recruiting
Impact of the Coronavirus (COVID-19) on Patients With Cancer
Source: ClinicalTrials.gov · Last updated 27 Apr 2026
Brief summary (registry, in English)
The purpose of this study is to understand the impact of COVID-19 on patients with cancer through a survey.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 30 Mar 2020
- Start date
- 8 Apr 2020
- Primary completion date
- Dec 2027
- Lead sponsor
- Stanford University
- NCT number
- NCT04330521
What you commit to
- Study type: Observational
- Planned participants: 50
- From 8 Apr 2020 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- 1.Patients who under the age of 18 years old.
Who the study is looking for
- The patients must be 18 years or older.
- Patients who opt in to complete the survey.
- Patients must have the capacity to verbally consent for the interview.
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stanford University School of Medicine Coordinator of this site? Confirm its status | Stanford | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.